Vitura Health Limited has released a press release.
Changes to clinical operations
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Vitura Health
- Sale of one millionth unit and record revenue in November
- Resolution of issues with major shareholder
- Response to ASX Price Query
- Quarterly Activities/Appendix 4C Cash Flow Report
- Commissioning of new Melbourne Distribution Centre
Later from Vitura Health
- Half Yearly Report and Accounts
- S&P DJI Announces March 2023 Quarterly Rebalance
- Receipt of Shareholder Notice
- Psychedelic joint venture with PharmAla Biotech
- Establishment of joint venture with Releaf Group
Follow Vitura Health into a list and get an email when it puts out news.
Follow Vitura Health